Literature DB >> 6040012

Experimental inclusion conjunctivitis in man. 3. Keratitis and other complications.

C Dawson, T R Wood, L Rose, L Hanna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6040012     DOI: 10.1001/archopht.1967.00980030343015

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  12 in total

1.  Protection against a chlamydial respiratory challenge by a chimeric vaccine formulated with the Chlamydia muridarum major outer membrane protein variable domains using the Neisseria lactamica porin B as a scaffold.

Authors:  Delia F Tifrea; Sukumar Pal; Jeff Fairman; Paola Massari; Luis M de la Maza
Journal:  NPJ Vaccines       Date:  2020-05-08       Impact factor: 7.344

2.  Otitis media in adults with chlamydial conjunctivitis.

Authors:  B T Goh; J M Hadley; N J Lomax; H C Patel; N D Viswalingam
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

3.  Newcastle disease conjunctivitis with subepithelial infiltrates.

Authors:  R H Hales; H B Ostler
Journal:  Br J Ophthalmol       Date:  1973-09       Impact factor: 4.638

4.  Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.

Authors:  Delia F Tifrea; Sukumar Pal; Jean-Luc Popot; Melanie J Cocco; Luis M de la Maza
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

5.  Chlamydial infections in children: a seroepidemiological study.

Authors:  J Gray; B Hovelius; P A Mårdh
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

6.  Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.

Authors:  Laszlo Kari; William M Whitmire; Deborah D Crane; Nathalie Reveneau; John H Carlson; Morgan M Goheen; Ellena M Peterson; Sukumar Pal; Luis M de la Maza; Harlan D Caldwell
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

7.  Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.

Authors:  Delia F Tifrea; Pooja Ralli-Jain; Sukumar Pal; Luis M de la Maza
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

8.  Chlamydial immunofluorescence serology in anterior uveitis.

Authors:  L Mattila; L Salminen; P Terho
Journal:  Br J Ophthalmol       Date:  1982-10       Impact factor: 4.638

9.  Computational modeling of TC0583 as a putative component of the Chlamydia muridarum V-type ATP synthase complex and assessment of its protective capabilities as a vaccine antigen.

Authors:  Delia F Tifrea; Michael L Barta; Sukumar Pal; P Scott Hefty; Luis M de la Maza
Journal:  Microbes Infect       Date:  2015-12-17       Impact factor: 2.700

10.  Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques.

Authors:  Dorothy L Patton; Andy Teng; Arlo Randall; Xiaowu Liang; Philip L Felgner; Luis M de la Maza
Journal:  J Proteomics       Date:  2014-05-24       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.